ArticlePharmaceuticals (Basel, Switzerland)2020

IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms.

Ewelina Motylewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.